NO174887C - Analogifremgangsmåte for fremstilling av terapeutisk aktive aryl- alkyl-pyrrol-2-carboxylsyreforbindelser - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive aryl- alkyl-pyrrol-2-carboxylsyreforbindelserInfo
- Publication number
- NO174887C NO174887C NO900432A NO900432A NO174887C NO 174887 C NO174887 C NO 174887C NO 900432 A NO900432 A NO 900432A NO 900432 A NO900432 A NO 900432A NO 174887 C NO174887 C NO 174887C
- Authority
- NO
- Norway
- Prior art keywords
- pyrrole
- alkyl
- carboxylic acid
- therapeutically active
- acid compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30414189A | 1989-01-31 | 1989-01-31 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO900432D0 NO900432D0 (no) | 1990-01-30 |
| NO900432L NO900432L (no) | 1990-08-01 |
| NO174887B NO174887B (no) | 1994-04-18 |
| NO174887C true NO174887C (no) | 1994-07-27 |
Family
ID=23175237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO900432A NO174887C (no) | 1989-01-31 | 1990-01-30 | Analogifremgangsmåte for fremstilling av terapeutisk aktive aryl- alkyl-pyrrol-2-carboxylsyreforbindelser |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0381141B1 (fr) |
| JP (1) | JP2841305B2 (fr) |
| KR (1) | KR0139288B1 (fr) |
| CN (1) | CN1022754C (fr) |
| AR (1) | AR245694A1 (fr) |
| AT (1) | ATE135702T1 (fr) |
| AU (1) | AU629290B2 (fr) |
| CA (1) | CA2008616C (fr) |
| DE (1) | DE69025967T2 (fr) |
| ES (1) | ES2087093T3 (fr) |
| FI (1) | FI900464A0 (fr) |
| HU (1) | HU209290B (fr) |
| IL (1) | IL93187A (fr) |
| NO (1) | NO174887C (fr) |
| NZ (1) | NZ232278A (fr) |
| PT (1) | PT93009A (fr) |
| ZA (1) | ZA90554B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| ZA90555B (en) * | 1989-01-31 | 1990-10-31 | Merrell Pharma Inc | Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions |
| EP2451779B1 (fr) | 2009-07-10 | 2014-09-03 | The General Hospital Corporation | Analogues de l'étomidate qui n'inhibent pas la synthèse de stéroïdes corticosurrénaux |
| CN102114430B (zh) * | 2009-12-30 | 2013-06-05 | 上海睿智化学研究有限公司 | 催化剂、其制备方法及n-烷基吡咯衍生物的制备方法 |
| PL2802325T3 (pl) | 2012-01-13 | 2017-11-30 | The General Hospital Corporation | Związki znieczulające i powiązane sposoby zastosowania |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4112112A (en) * | 1976-06-29 | 1978-09-05 | Merck & Co., Inc. | Pyrrolo[2,1-b] [3]benzazepines useful for producing a skeletal muscle relaxing or tranquilizing effect |
| JPS54128567A (en) * | 1978-03-28 | 1979-10-05 | Teijin Ltd | 1-substituted-4-acyl-2-pyrrolecarboxylic acid derivative |
-
1990
- 1990-01-25 CA CA002008616A patent/CA2008616C/fr not_active Expired - Fee Related
- 1990-01-25 AR AR90316008A patent/AR245694A1/es active
- 1990-01-25 ZA ZA90554A patent/ZA90554B/xx unknown
- 1990-01-25 AU AU48759/90A patent/AU629290B2/en not_active Ceased
- 1990-01-26 IL IL9318790A patent/IL93187A/en not_active IP Right Cessation
- 1990-01-29 JP JP2016304A patent/JP2841305B2/ja not_active Expired - Fee Related
- 1990-01-29 NZ NZ232278A patent/NZ232278A/en unknown
- 1990-01-30 AT AT90101809T patent/ATE135702T1/de not_active IP Right Cessation
- 1990-01-30 NO NO900432A patent/NO174887C/no unknown
- 1990-01-30 ES ES90101809T patent/ES2087093T3/es not_active Expired - Lifetime
- 1990-01-30 HU HU90592A patent/HU209290B/hu not_active IP Right Cessation
- 1990-01-30 PT PT93009A patent/PT93009A/pt not_active Application Discontinuation
- 1990-01-30 DE DE69025967T patent/DE69025967T2/de not_active Expired - Fee Related
- 1990-01-30 KR KR1019900000994A patent/KR0139288B1/ko not_active IP Right Cessation
- 1990-01-30 EP EP90101809A patent/EP0381141B1/fr not_active Expired - Lifetime
- 1990-01-30 FI FI900464A patent/FI900464A0/fi not_active IP Right Cessation
- 1990-01-31 CN CN90100431A patent/CN1022754C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0381141A3 (fr) | 1991-11-21 |
| EP0381141B1 (fr) | 1996-03-20 |
| CN1044653A (zh) | 1990-08-15 |
| FI900464A0 (fi) | 1990-01-30 |
| IL93187A0 (en) | 1990-11-05 |
| HU900592D0 (en) | 1990-04-28 |
| JP2841305B2 (ja) | 1998-12-24 |
| AR245694A1 (es) | 1994-02-28 |
| DE69025967T2 (de) | 1996-08-29 |
| ZA90554B (en) | 1990-10-31 |
| NO900432L (no) | 1990-08-01 |
| PT93009A (pt) | 1990-07-31 |
| EP0381141A2 (fr) | 1990-08-08 |
| KR0139288B1 (ko) | 1998-05-15 |
| ES2087093T3 (es) | 1996-07-16 |
| AU4875990A (en) | 1990-08-09 |
| AU629290B2 (en) | 1992-10-01 |
| HUT53868A (en) | 1990-12-28 |
| CA2008616A1 (fr) | 1990-07-31 |
| IL93187A (en) | 1994-12-29 |
| NO900432D0 (no) | 1990-01-30 |
| DE69025967D1 (de) | 1996-04-25 |
| CN1022754C (zh) | 1993-11-17 |
| JPH02247165A (ja) | 1990-10-02 |
| CA2008616C (fr) | 2000-07-18 |
| NZ232278A (en) | 1992-07-28 |
| ATE135702T1 (de) | 1996-04-15 |
| HU209290B (en) | 1994-04-28 |
| KR900011725A (ko) | 1990-08-02 |
| NO174887B (no) | 1994-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO175371C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyrederivater | |
| NO174385C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive spiro-substituerte glutamid-derivater | |
| NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO180586C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler | |
| NO176758C (no) | Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner | |
| NO177387C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| FI96601C (fi) | Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi | |
| NO174959C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater | |
| NO175429C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater | |
| NO178967C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater | |
| NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
| FI871087A (fi) | Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi | |
| FI884471A0 (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
| NO177096C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner | |
| NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
| NO174892C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser | |
| NO175781C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser | |
| NO176477C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater | |
| NO174200C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive |